Latest news with #AssociationforDiagnostics&LaboratoryMedicine
Malaysian Reserve
30-07-2025
- Business
- Malaysian Reserve
QuidelOrtho Recognized with Three Awards in 2025 IMV ServiceTrak™
SAN DIEGO, July 29, 2025 /PRNewswire/ — QuidelOrtho earned three awards and top rankings in the 2025 IMV ServiceTrak™ Awards, presented at the Association for Diagnostics & Laboratory Medicine, recognizing excellence in customer satisfaction across key performance areas. Awards: Chemistry Best overall system performance Integrated Systems Best overall system performance Best overall service Chemistry Best overall system performance Integrated Systems Best overall system performance Best overall service Best overall system performance Best overall system performance Best overall service Top Rankings: QuidelOrtho received top rankings in several key categories for Integrated Systems, including: QuidelOrtho received top rankings in several key categories for Integrated Systems, including: #1 Overall Net Promoter Score (NPS) by Manufacturer #1 Overall Manufacturer Performance #1 Overall Service Engineer Performance #1 Overall Training Performance #1 Overall Net Promoter Score (NPS) by Manufacturer #1 Overall Manufacturer Performance #1 Overall Service Engineer Performance #1 Overall Training Performance #1 Overall Net Promoter Score (NPS) by Manufacturer #1 Overall Manufacturer Performance #1 Overall Service Engineer Performance #1 Overall Training Performance QuidelOrtho invested in initiatives focused on what customers value most, driving significant advances in reliability, product quality and service. This commitment delivered a 17-point increase in NPS, the largest gain in the category, reflecting higher customer loyalty and satisfaction. Learn how QuidelOrtho prioritizes customers' beliefs and values to deliver solutions. These awards and rankings showcase QuidelOrtho's comprehensive approach to enhancing both product and service in clinical diagnostics. A key part of this success has been investing in employee development through specialized customer experience training, fueling continued progress and stronger relationships with customers. QuidelOrtho remains committed to ongoing innovation and delivering smart, customer-focused solutions that elevate laboratory efficiency and outcomes. Key Quotes: Karen Taylor, Senior Vice President, Customer Experience, QuidelOrtho 'We're honored to be recognized with three awards and top rankings in this year's IMV ServiceTrak Awards, but even more so, we're grateful to our customers for their ongoing trust and collaboration. These results reflect their feedback and our shared commitment to improving outcomes together. Our QuidelOrthoCQ™ solutions are designed to give customers the freedom to focus on what matters most. We'll continue listening and evolving to better support their success.' Additional Resources: Listen to Karen Taylor's Repertoire Magazine Interview: Freedom to Focus: How QuidelOrthoCQ is creating delightful customer experiences About IMV ServiceTrakThe IMV ServiceTrak Clinical Laboratory Awards are the result of independent market research assessing manufacturer performance in the in-vitro diagnostics space. IMV's annual report represents an independent analysis of customer satisfaction with instrument manufacturers, system performance and service received. IMV's ServiceTrak Clinical Laboratory Awards are based on feedback from laboratory testing professionals in 1,800 clinical testing locations, representing 4,100 instruments. For over 25 years, IMV ServiceTrak has provided independent analysis of service trends and manufacturer ratings in laboratory diagnostics. About QuidelOrtho Corporation QuidelOrtho Corporation (Nasdaq: QDEL) is a global provider of innovative diagnostic testing solutions. From infectious diseases to cardiac biomarkers to women's health, QuidelOrtho transforms the power of diagnostics into a healthier future through science, innovation and accessibility. Learn more at Investor Contact: Media Contact: Juliet Cunningham D. Nikki Wheeler Vice President, Investor Relations Senior Director, Corporate IR@ Communications Media@
Cision Canada
23-07-2025
- Business
- Cision Canada
Seegene unveils the world's first unattended PCR automation, igniting a global diagnostic paradigm shift at ADLM 2025
Fully Unmanned— CURECA™, the 100% Automated Diagnostic System Defining the Future Gold Standard, Debuts in Chicago , July 28–31 , July 28–31 Unifying global diagnostic data - STAgora™, the big data platform set to transform the future of diagnostics Pilot partnerships to offer early access to the new diagnostic paradigm, with selected institutions engaged by year-end SEOUL, South Korea , July 23, 2025 /CNW/ -- Seegene Inc., a global leader in molecular diagnostics, announced today that it will unveil its fully automated PCR testing system, CURECA™, and its data analytics platform, STAgora™, at ADLM 2025 (Association for Diagnostics & Laboratory Medicine), the world's largest diagnostics conference, taking place in Chicago from July 28 to 31 . With the introduction of these new technologies, Seegene declares a transformative shift in the global diagnostics paradigm. Automating every step of PCR Testing for enhanced efficiency and accuracy Continue Reading Seegene will present a live demonstration of CURECA™ (pictured), its next-generation fully automated PCR testing system in ADLM 2025, held in Chicago from July 28 to 31. CURECA™ integrates three core modules: a prep module for pre-analytical processing, a diagnostic module for assay execution, and a software module for data analysis. CURECA™ is the world's first system to fully automate the entire PCR testing process – from specimen storage and pre-treatment to nucleic acid extraction, amplification, and result analysis – without any human intervention. Designed for 24/7 continuous operation, the system minimizes human error and dramatically improves the consistency and reliability of the test results. A key breakthrough lies in its fully automated prep module, which addresses one of the most burdensome and error-prone stages in diagnostic workflows. Pre-treatment has traditionally been a major challenge, particularly when dealing with diverse sample types such as urine, blood, sputum, and stool. Lab technicians often carry out repetitive manual tasks over extended hours, and variations in skill level can result in inconsistent outcomes. Stool samples, especially, have posed serious automation barriers due to their viscosity and particulates, requiring heavy manual handling. The prep module of CURECA™ system is the first to fully automate pre-treatment process across all major specimen types – including stool – overcoming longstanding obstacles in laboratory operations. This innovation reduces labor demands, expands sample throughput, and enhances overall operational and cost efficiency. It also shifts the role of laboratory personnel from manual processing to higher-level responsibilities, such as data analysis and clinical interpretation – helping labs better leverage their workforce in high-volume testing environments. In addition, the prep module is applicable beyond PCR diagnostics. It supports pre-treatment for other disciplines, including clinical chemistry and immunoassays, marking a significant step forward in automation across the broader diagnostics market. Its modular architecture allows for flexible configuration and deployment tailored to the size, layout, and needs of each laboratory. STAogra™ – Real-Time Global Data Integration Empowering Personalized Care Also unveiled at ADLM 2025, STAgora™ is Seegene's statistical platform that collects and analyzes real-time PCR diagnostic data to support clinical decision-making. By aggregating test data uploaded from hospitals around the world, the platform provides integrated insights into regional infection trends, hospital-level positivity rates, and patterns of co-infection. It also offers more than 40 statistical tools tailored for clinical support. With STAgora™, healthcare providers can compare individual patient test results with local and regional epidemiological data, enabling more precise, data-driven treatment strategies. The platform allows clinicians to evaluate infection trends at both patient and community levels, improving the accuracy and speed of diagnosis and care planning. By delivering rapid, reliable insights through this kind of comprehensive analysis, STAgora™ is expected to become an essential analytical tool for clinical decision-making. Expanding Global Collaboration via Technology Sharing and Strategic Partnerships Building on its presence at ADLM 2025, Seegene aims to broaden access to CURECA™ and STAgora™ by offering early pilot experiences and establishing new global partnerships. Earlier this year, CURECA™ attracted strong interest at ESCMID Global 2025, one of Europe's leading clinical microbiology and infectious disease congresses. To strengthen its R&D and manufacturing capacity in the United States , Seegene has established local subsidiaries, including Seegene Technologies and Seegene CURECA. "CURECA™ and STAgora™ are more than just diagnostics equipment or software—they represent a new global standard that will redefine diagnostics in clinical settings around the world. We will continue to share the many technological assets we've built over the years and based on this foundation, we are committed to driving fundamental innovation across the global diagnostics ecosystem." Said Daniel Shin , Executive Vice President, Chief of Global Sales & Marketing at Seegene. Disclaimer The product is currently in a pre-commercialization phase. The configuration presented at ADLM 2025 is for demonstration purposes only and may differ in functionality, specifications, and components from the final commercial version. This material is intended solely to introduce the technology and does not constitute an advertisement for product sales. About Seegene Seegene has more than 20 years of dedicated experience in R&D, manufacturing, and business related to syndromic real-time PCR technologies. This expertise was particularly highlighted during the COVID-19 pandemic when Seegene provided over 340 million COVID-19 tests to more than 100 countries worldwide. The core feature of Seegene's syndromic real-time PCR technology is the ability to simultaneously test for 14 pathogens that cause similar signs and symptoms in a single tube with quantitative information. Visit: and follow SOURCE Seegene Inc. Hyeongjoo Park, [email protected]
Yahoo
02-06-2025
- Health
- Yahoo
ADLM honors 2025 award winners for advancing laboratory medicine and patient care
WASHINGTON, June 2, 2025 /PRNewswire/ -- The Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) is proud to announce the recipients of the 2025 ADLM and Academy of Diagnostics & Laboratory Medicine Awards. Through this annual awards program, ADLM and its Academy strive to support laboratory medicine professionals in all stages of their careers and to build awareness of the essential role that clinical laboratory testing plays in improving patient health. 2025 ADLM AWARD WINNERS Wallace H. Coulter Lectureship AwardHeidi Rehm, PhD, FACMG Massachusetts General Hospital Outstanding Lifetime Achievement Award in Clinical Chemistry and Laboratory MedicineLarry J. Kricka, DPhil, FACB, CSci, CChem, FRSC, FRCPath University of Pennsylvania Outstanding Contributions Through Service to the Profession of Clinical ChemistryAlison Woodworth, PhD, DABCC, FADLM CTI Clinical Trials & Consulting Outstanding Contributions to Education in Clinical Chemistry David J. Anderson, PhD Cleveland State University Outstanding Scientific Achievements by a Young Investigator Nicholas C. Spies, MD University of Utah/ARUP Laboratories Clinical Laboratory Scientist Achievement Award Michelle R. Campbell, MS, MLS(ASCP)CMMBCM,SCCM Mayo Clinic Humans of ADLM – DEI Leadership Award (Individual Category) Dina N. Greene, PhD, DABCC University of Washington Humans of ADLM – DEI Leadership Award (Team Category) WashU Section of Pathology Informatics Washington University School of Medicine ADLM Past President's Award Octavia M. Peck Palmer, PhD, FADLM University of Pittsburgh Medical Center ADLM General Research Grant Recipient Lejla Alić, MD, PhD University of Sarajevo – Faculty of Medicine Helen Free Travel Grant Recipient Daniel Barry, MLS(ASCP)CMThe Children's Hospital of Philadelphia 2025 ACADEMY OF DIAGNOSTICS & LABORATORY MEDICINE AWARD WINNERS Award for Outstanding Contributions to Clinical Chemistry in a Selected Area of ResearchTony Hu, PhD, FNAI, FAIMBE Tulane University, School of Medicine Professor Alvin Dubin Award for Outstanding Contributions to the Profession and the Academy Alison Woodworth, PhD, DABCC, FADLM CTI Clinical Trials & Consulting George Grannis Award for Excellence in Research and Scientific Publication Vahid Azimi, MD, MS Alameda Health System "A hearty congratulations to this year's award winners, whose dedication to excellence and innovative work in the field of laboratory medicine has been essential to advancing healthcare," said ADLM President Dr. Anthony Killeen. "Their exceptional achievements in research, service, education, and advocacy have advanced the ability of lab experts to solve challenging medical problems and to ensure that high quality care is accessible to all." The 2025 ADLM and Academy of Diagnostics & Laboratory Medicine Award winners will be recognized during the plenary sessions at ADLM 2025, held in Chicago from July 27-31. About the Association for Diagnostics & Laboratory Medicine (ADLM) Dedicated to achieving better health for all through laboratory medicine, ADLM (formerly AACC) unites more than 70,000 clinical laboratory professionals, physicians, research scientists, and business leaders from 110 countries around the world. Our community is at the forefront of laboratory medicine's diverse subdisciplines, including clinical chemistry, molecular diagnostics, mass spectrometry, clinical microbiology, and data science, and is comprised of individuals holding the spectrum of lab-related professional degrees, certifications, and credentials. Since 1948, ADLM has championed the advancement of laboratory medicine by fostering scientific collaboration, knowledge sharing, and the development of innovative solutions that enhance health outcomes. For more information, visit Christine DeLongADLMDirector, Editorial and Media Relations(p) 202.835.8722cdelong@ Bill MaloneADLMSenior Director, Strategic Communications(p) 202.835.8756bmalone@ View original content to download multimedia: SOURCE Association for Diagnostics & Laboratory Medicine (ADLM) Sign in to access your portfolio
